In 2008, more than 40,000 women died from breast cancer in the United States. Breast cancer is a devastating public health concern that is best addressed through early detection and treatment. Once a suspicious breast finding is detected, only a biopsy can determine whether it is benign or malignant. Stereotactic breast biopsy uses mammography, ultrasound and occasionally magnetic resonance imaging to guide the placement of a biopsy needle into the breast. A computer plots the coordinates, which help guide the needle to the precise location of a mass or suspicious finding to extract a tissue sample. Stereotactic breast biopsy has its limitations, but its benefits include decreased patient pain and anxiety, quick recovery time and cost-effectiveness. Most importantly, it can prevent women with benign findings from undergoing surgical biopsy.
展开▼
